Please login to the form below

Article 50

This page shows the latest Article 50 news and features for those working in and with pharma, biotech and healthcare.

No deal or revoke looming as fourth vote on Brexit nears

So weeks after the EU agreed an extension of Article 50 to 31 October – now just over 160 days away – there seems to have been little progress, despite appeals by President ... Number 10 had been informally saying that if the deals doesn’t get

Latest news

UK heart deaths rise for first time in 50 years

50 years, warns a new report from charity the British Heart Foundation.
Brexit "having impact on EU drug development”

There’s little sign that the Brexit pressure will let up for a few months at least, now that a delay to the Article 50 date has been set to 31
No-deal risk recedes, but new Brexit delay adds to uncertainty

With the extension of Article 50, we will work with Government to consider how best to prepare and review whether current plans for a no deal Brexit are still appropriate.”.
Pharma asked to consider 5 things as no-deal Brexit looms again

If ‘no-deal’ were rejected, Article 50 would be revoked and an inquiry set up to establish whether any form of Brexit could command a majority.
UK business: Brexit deadlock causing “frustration and anger”

B ‘managed no-deal’ option with an extended transition period; accepting a no-deal exit on 12 April; revoking Article 50 and halting Brexit; and Common Market 2.0 – also known ... When it comes to any further extension to Article 50, which would be

More from news
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest Intelligence

Leave or remain? Winning the employee referendum

killer question: ‘Should I stay or should I go?’ Our decision to trigger the employee equivalent of Article 50 will normally be influenced by our experiences with our current employer. ... We all know you. can’t run a business on 50% turnover, but
The Patient Safety Challenge

The goal that the WHO’s document set is to ‘gain worldwide commitment and action to reduce severe, avoidable medication-related harm by 50% in the next five years’. ... International research collaboration. In this article, we describe a programme
Macron, Merkel and May: implications of the 2017 elections for the life science industry

50 negotiations, which could result in a new Government with a different set of policy priorities and an alternative approach to Brexit. ... However, the Chancellor, Philip Hammond, welcomed the CBI’s call for an ‘indefinite’ transition period
Brexit: the facts (and the alternative facts)

How Brexit affects pharma. The British Government submitted Article 50 in March 2017, formerly giving giving notice its intent to leave the EU.
Brexit: Implications for the pharma industry

Notice under Article 50 was given at the end of March 2017, triggering the start of the two-year period during which the UK’s withdrawal from the EU will be

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

News: Research Partnership is listed in the Alantra Pharma Fast 50 annual report

The best performing privately-owned UK pharmaceutical businesses were revealed earlier this month with the publication of Pharma Times’ Alantra Pharma Fast 50 annual report.
50 questions for delivering an exceptional healthcare brand experience

Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need. ... That's why we have created this 50-question checklist to help you deliver an exceptional brand
Random42 Named in Alantra’s Pharma Fast 50.

The London based scientific communication studio have been named in this year’s Pharma Fast 50, an annual ranking of the UK’s fastest-growing companies within the pharmaceutical industry. ... For more on the Pharma Fast 50 read the full article: .
Research Partnership has been ranked in the Pharma Times Pharma Fast 50

Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research Partnership

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Lead Copywriter: Competitive

Healthcare Senior Account Manager: Competitive

Medical Editor: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Healthcare Account Director: Competitive

Account Director – Creative Healthcare Communications: Competative

PMHub

Add my company

Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

The search for effective drug treatments for COVID-19: PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....